Re-CODE is a new program in which Kay teaches you how to prevent the symptoms of Alzheimer’s, for you and your loved ones.
Kay Jennings, BSN, MHSA, MSN, PMHNP-BC, is trained by Dale Bredesen MD, the internationally recognized expert on Alzheimer’s and the brilliant mind behind The Bredesen ReCODE Protocol – the groundbreaking and proven treatment approach to the prevention and reversal of cognitive decline.
Alzheimer’s is the #3 cause of death in America, with 65% of its victims being women – and 60% of caregivers being women as well. No matter your age or your current health, you NEED to know about Dr. Dale Bredesen’s approach to preventing and reversing Alzheimer’s Disease. And Kay Jennings can introduce you to this life changing protocol, utilizing the comprehensive and personalized ReCODE (Reversing Cognitive Decline) process.
Dr. Bredesen’s website, www.mpicognition.com, offers important details about The Bredesen Protocol:
“The Protocol provides a comprehensive personalized program designed to improve cognition and reverse the cognitive decline of SCI, MCI, and early Alzheimer’s disease. Continued research and testing by Dr. Bredesen… has identified new and previously unrecognized causes of Alzheimer’s disease”.
Importantly, The Bredesen Protocol looks beyond the ‘what’ of chronic illness and searches for the ‘why’. According to Dr. Bredesen:
“20th-century medicine makes a diagnosis of what—Alzheimer’s or cardiovascular disease or hypertension—without understanding why. 20th-century medicine uses a one-size-fits-all, monotherapeutic approach, and has been largely unsuccessful in treating chronic illnesses such as Alzheimer’s disease, other neurodegenerative conditions, cancer, and cerebrovascular disease.”
“21st-century medicine is completely different: larger data sets are used to identify network changes that characterize chronic illnesses, revealing the “why” for each person—this is the etiodiagnosis. Prevention and early symptomatic approaches are emphasized. Addressing the cause of each condition in a comprehensive and personalized, programmatic way leads to improved outcomes, and each program is repeatedly optimized over time, to ensure sustained improvement.”
“Such an approach was used to bring about the first reversal of cognitive decline in patients with early Alzheimer’s disease or its precursors, MCI (mild cognitive impairment) and SCI (subjective cognitive impairment), published in 2014 (Bredesen, Aging 2014).”